ENTRY       D10514                      Drug
NAME        Dacomitinib (USAN);
            Dacomitinib hydrate (JAN);
            Vizimpro (TN)
PRODUCT     VIZIMPRO (Pfizer Laboratories Div Pfizer)
            VIZIMPRO (U.S. Pharmaceuticals)
FORMULA     C24H25ClFN5O2. H2O
EXACT_MASS  487.1786
MOL_WEIGHT  487.9543
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
               DG03162  EGFR inhibitor
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
REMARK      Therapeutic category: 4291
            ATC code: L01EB07
            Chemical structure group: DG01793
            Product (DG01793): D10514<JP/US>
EFFICACY    Antineoplastic, Receptor tyrosine kinase inhibitor
  DISEASE   Non-small cell lung cancer (EGFR mutation positive) [DS:H00014]
TARGET      EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]
            ERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]
            ERBB4 (HER4) [HSA:2066] [KO:K05085]
  PATHWAY   hsa04012(1956+2064+2066)  ErbB signaling pathway
            hsa04020(1956+2064+2066)  Calcium signaling pathway
            hsa05205(1956+2064+2066)  Proteoglycans in cancer
            hsa05223(1956+2064)  Non-small cell lung cancer
INTERACTION CYP inhibition: CYP2D6 [HSA:1565]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
                 L01EB07 Dacomitinib
                  D10514  Dacomitinib (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Dacomitinib
                D10514  Dacomitinib (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D10514  Dacomitinib (USAN); Dacomitinib hydrate (JAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03162  EGFR inhibitor
                 DG01793  Dacomitinib
                  D10514  Dacomitinib
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG01793  Dacomitinib
                D10514  Dacomitinib
            Drug classes [BR:br08332]
             Antineoplastic
              DG03162  EGFR inhibitor
               D10514  Dacomitinib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR* [HSA_VAR:1956v2]
                 D10514  Dacomitinib (USAN) &lt;JP/US&gt;
                ERBB2 (HER2, CD340)
                 D10514  Dacomitinib (USAN) &lt;JP/US&gt;
                ERBB4 (HER4)
                 D10514  Dacomitinib (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10514
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10514
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10514
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10514
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10514
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D10514
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03162  EGFR inhibitor
                 DG01793  Dacomitinib
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG01793  Dacomitinib
DBLINKS     CAS: 1042385-75-0
            PubChem: 172232607
ATOM        34
            1   C8y C    16.1544  -13.1441
            2   C8y C    16.1544  -14.5430
            3   C8x C    14.9654  -15.2424
            4   C8y C    13.7763  -14.5430
            5   C8y C    13.7763  -13.1441
            6   C8x C    14.9654  -12.4447
            7   C8y C    12.5174  -15.2424
            8   N5x N    11.3283  -14.5430
            9   C8x C    11.3283  -13.1441
            10  N5x N    12.5174  -12.4447
            11  N1b N    17.4134  -15.2424
            12  O2a O    17.4134  -12.4447
            13  N1b N    12.5174  -16.6413
            14  C1a C    17.4134  -11.0458
            15  C5a C    18.6024  -14.5430
            16  C2b C    19.8614  -15.2424
            17  O5a O    18.6024  -13.1441
            18  C2b C    20.9805  -14.5430
            19  C1b C    22.2395  -15.2424
            20  N1y N    23.4285  -14.4730
            21  C1x C    24.6175  -15.1725
            22  C1x C    25.8065  -14.4730
            23  C1x C    25.8066  -13.0742
            24  C1x C    24.6175  -12.3747
            25  C1x C    23.4285  -13.0742
            26  C8y C    13.7064  -17.3407
            27  C8x C    13.7064  -18.7396
            28  C8y C    14.9654  -19.4390
            29  C8y C    16.1544  -18.7396
            30  C8x C    16.1544  -17.3407
            31  C8x C    14.9654  -16.6413
            32  X   Cl   14.9654  -20.8379
            33  X   F    17.3434  -19.4390
            34  O0  O    23.9400  -19.2500
BOND        36
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11    5  10 1
            12    2  11 1
            13    1  12 1
            14    7  13 1
            15   12  14 1
            16   11  15 1
            17   15  16 1
            18   15  17 2
            19   16  18 2
            20   18  19 1
            21   19  20 1
            22   20  21 1
            23   21  22 1
            24   22  23 1
            25   23  24 1
            26   24  25 1
            27   20  25 1
            28   13  26 1
            29   26  27 2
            30   27  28 1
            31   28  29 2
            32   29  30 1
            33   30  31 2
            34   26  31 1
            35   28  32 1
            36   29  33 1
///
